Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1.09B
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
10.8M
-
Shares change
-
+488K
-
Total reported value, excl. options
-
$231M
-
Value change
-
+$10.5M
-
Number of buys
-
21
-
Number of sells
-
-11
-
Price
-
$21.35
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q1 2018
41 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q1 2018.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.8M shares
of 1.09B outstanding shares and own 0.99% of the company stock.
Largest 10 shareholders include FMR LLC (4.87M shares), GILDER GAGNON HOWE & CO LLC (904K shares), Myriad Asset Management Ltd. (891K shares), PRICE T ROWE ASSOCIATES INC /MD/ (794K shares), ORBIMED ADVISORS LLC (658K shares), Segantii Capital Management Ltd (385K shares), Cormorant Asset Management, LP (333K shares), Rock Springs Capital Management LP (295K shares), Vivo Capital, LLC (284K shares), and Marshall Wace North America L.P. (208K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.